Consumer Research
NEWS: Psilocybin Could Help Prevent Debilitating Nerve Damage Caused by Chemotherapy
AUSTIN – A new study from The University of Texas MD ...
Grön Scatters Pearls Over Four States at Once
PORTLAND – Grön officially announced that its flagship Pearls line ...
Headset Settles Federal PPP Loan Claims
SEATTLE – Headset Inc. agreed to pay more than $1 ...
California Tightens Rules on Cannabis Packaging Attractive to Kids
LOS ANGELES – California's effort to draw a sharper legal line around child-appealing Cannabis packaging has cleared the legislature, sending AB 2249 to Gov. Gavin Newsom for final action. The measure, sponsored by Assemblymember Jacqui ...
Massachusetts Opens New Round of Social Equity Applications for Cannabis
BOSTON – The Massachusetts Cannabis Control Commission will begin accepting new applications for its Social Equity Program on September 1, with the intake period running through November 30. The commission will also hold four virtual ...
Fewer Americans Drink Alcohol as Cannabis Shows Up to the Party
LOS ANGELES – For generations, alcohol held an unquestioned place at the center of adult social life. A drink after work. Beer at the game. Wine with dinner. That relationship is now under measurable pressure: ...
Texas’s Dazed Inc Claims Expansion and Buyback Strategy
AUSTIN – Dazed Inc., formerly MedX Holdings, Inc., released a corporate update covering retail expansion, Q2 2026 financial results, a planned stock buyback, and product distribution. The company announced a signed franchise agreement for a ...
Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III
WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement Administration has helped enforce federal Cannabis prohibition. This week, the DEA formally argued that Cannabis no longer belongs in Schedule I. In its final written ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
CRB Monitor and NCS Analytics Partner to Bridge the Cannabis Compliance Data Gap
DENVER – Two of the industry's most data-intensive platforms that have long operated on parallel tracks in the Cannabis compliance space announced a formal partnership, combining regulatory licensing records with real-time operational analytics into a ...
Decibel Reports Q2 2026 Financial Results
CALGARY – Decibel Cannabis Co. Inc. reported second-quarter net revenue of $35.6 million for the period ended June 30, 2026, the best three-month result in the company's history. A licensed Canadian Cannabis producer simultaneously raised ...
Organigram Pulls Sanity Group Into a Single Global Structure
TORONTO – Organigram Global Inc. did not wait out the calendar. Roughly four months after the April 2026 closing of its acquisition of Sanity Group GmbH, the Canadian Cannabis producer announced an accelerated integration of ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
LEEF Brands Reports Q1 2026 Financial Results
VANCOUVER – LEEF Brands Inc. reported its strongest financial quarter since inception, showing marked operational progress and turning what had been a loss position a year ago into meaningful profitability, all without adding a single ...
GTI Reports Q1 2026 Financial Results
CHICAGO – Green Thumb Industries Inc. released its first-quarter 2026 financial results, highlighting steady performance in a market still marked by price competition and variable demand. The multistate Cannabis operator posted steady revenue growth, alongside ...
Target Expands Hemp-Derived THC Beverage Sales Area
NEW YORK – Target is broadening its reach in the hemp-derived THC beverage category, adding the products to more than 300 stores across Florida, Texas and parts of Illinois. The mass retailer confirmed the move ...
Cannara Biotech Wraps Up Medican Organic Acquisition
MONTREAL – Cannara Biotech Inc. announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. for an aggregate purchase price of $2.8 million. On the surface, that's a modest ...
Aprio Targets Cannabis Sector in Price Kong Acquisition
ATLANTA-PHOENIX – Aprio, the 20th largest business advisory and accounting firm in the United States, announced it had entered into an agreement to acquire Price Kong, a Phoenix-based CPA and advisory firm. The transaction, effective ...
RYTHM Reports Q1 2026 Financial Results
ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at ...
High Tide Scores Big in Germany Through Remexian Distribution
CALGARY-BERLIN – High Tide Inc. reported that its majority-owned German subsidiary, Remexian Pharma GmbH, distributed 7.6 tons of medical Cannabis flower into the German market during the second fiscal quarter ended April 30, 2026 – ...
Curaleaf Reports Q1 2026 Financial Results
STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began ...
LeafLink Releases 2026 Wholesale Cannabis Pricing Guide
NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal ...
Psilocybin Shows Promise for Those Ready to Break Free from Nicotine
BALTIMORE – Researchers at Johns Hopkins University have published findings from a pilot randomized clinical trial that points to potential advantages of psilocybin-assisted therapy over standard nicotine replacement for helping adults quit cigarettes. Published in ...
Hall of Flowers Relocates Northern California Event to Sacramento
LOS ANGELES – After eight years in Santa Rosa, the B2B Cannabis trade show Hall of Flowers is moving its Northern California event to the Cal Expo exhibition halls in Sacramento. The newly confirmed dates, ...
Vireo to Acquire FLUENT in All-Stock Deal
LOS ANGELES – Vireo Growth Inc. announced it has signed a definitive agreement to absorb FLUENT Corp. in an all-stock transaction, a deal that, if approved, would make Vireo the third-largest operator in medical-only Florida's ...
DEA Assigns Specific Schedule I Listing and Drug Code to HHC
WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal ...
Allied Market Research: Global Cannabis Market to Generate $149B by 2031
PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, ...
Curaleaf Takes Full Control of Germany’s Four 20 Pharma
STAMFORD – Curaleaf Holdings Inc. closed the final chapter of a four-year German acquisition story, completing the buyout of the remaining 45% stake it did not previously own in Four 20 Pharma GmbH, a move ...
Verano Reports Q1 2026 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the three months ended March 31, 2026, showing revenue largely in line with recent quarters as the multi-state Cannabis operator managed wholesale pressures while leaning ...
SNDL Reports Q1 2026 Financial and Operational Results
EDMONTON – SNDL Inc. disclosed a 4.4% drop in net revenue for the three months ended March 31, 2026, as softness in both its Cannabis and liquor businesses weighed on results. The company, which operates ...
Hemp THC Ban Moves Closer as Congressional Fixes Collapse
WASHINGTON – The federal clock on hemp-derived THC products is ticking with no sign of relief from Capitol Hill. Amendments filed last week to delay, or in one case accelerate, the November 12 ban on ...
Helus Pharma Teams Up with TARA Mind on Veteran Mental Health Efforts
NEW YORK – Helus Pharma, a clinical-stage biopharmaceutical company focused on developing novel serotonergic agonists (NSAs) to treat mental health conditions, announced it has joined forces with TARA Mind to help recruit veterans for its ...
Rescheduling: What it Actually Means for US Cannabis
LOS ANGELES – For years, the Cannabis industry's most reliable tradition has been misreading federal signals. When the DEA floated rescheduling proposals, operators popped champagne. When states passed adult-use laws, investors rushed in ahead of ...
DEA Opens Federal Registration Portal for Medical Cannabis Dispensaries
WASHINGTON – The Drug Enforcement Administration (DEA) is set to launch its new online portal on Wednesday, 29 April at 9:00 AM EST, facilitating the application process for state-licensed medical Cannabis dispensaries seeking federal registration ...
Blind Spot: Cannabis Industry Falls Short on Communications
NEW YORK – Legal Cannabis brought in $38.5 billion in revenue in 2024. Whitney Economics estimated that figure to drop to between $29.1 billion and $29.6 billion in 2025, due to falling prices, tax pressures, ...
